SEPTERNA INC (SEPN) Stock Price, Quote, News and Overview
NASDAQ:SEPN - Nasdaq - US81734D1046 - Common Stock - Currency: USD
SEPN Quote, Performance and Key Statistics
10.47
-0.02 (-0.19%)
The current stock price of SEPN is 10.47 USD. In the past month the price increased by 15.56%.
SEPN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 55.43 | 722.87B | ||
| JNJ | JOHNSON & JOHNSON | 14.9 | 360.41B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 20.38 | 327.79B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.93 | 228.66B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 15.9 | 216.88B | ||
| MRK | MERCK & CO. INC. | 10.15 | 198.52B | ||
| PFE | PFIZER INC | 7.47 | 136.28B | ||
| SNY | SANOFI-ADR | 10.68 | 116.48B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.38 | 95.36B | ||
| GSK | GSK PLC-SPON ADR | 8.61 | 77.15B | ||
| ZTS | ZOETIS INC | 26.11 | 69.97B | ||
| HLN | HALEON PLC-ADR | 21.24 | 46.84B |
Related stock screener links
About SEPN
Company Profile
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. The company is headquartered in South San Francisco, California and currently employs 75 full-time employees. The company went IPO on 2024-10-25. The firm is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. The company is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. The company is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Company Info
SEPTERNA INC
250 East Grand Avenue, Suite 65
South San Francisco CALIFORNIA US
Employees: 75
Phone: 16503383533
SEPTERNA INC / SEPN FAQ
What is the stock price of SEPTERNA INC today?
The current stock price of SEPN is 10.47 USD. The price decreased by -0.19% in the last trading session.
What is the ticker symbol for SEPTERNA INC stock?
The exchange symbol of SEPTERNA INC is SEPN and it is listed on the Nasdaq exchange.
On which exchange is SEPN stock listed?
SEPN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SEPTERNA INC stock?
10 analysts have analysed SEPN and the average price target is 19.38 USD. This implies a price increase of 85.1% is expected in the next year compared to the current price of 10.47. Check the SEPTERNA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SEPTERNA INC worth?
SEPTERNA INC (SEPN) has a market capitalization of 466.54M USD. This makes SEPN a Small Cap stock.
How many employees does SEPTERNA INC have?
SEPTERNA INC (SEPN) currently has 75 employees.
What are the support and resistance levels for SEPTERNA INC (SEPN) stock?
SEPTERNA INC (SEPN) has a support level at 10.32 and a resistance level at 10.48. Check the full technical report for a detailed analysis of SEPN support and resistance levels.
Is SEPTERNA INC (SEPN) expected to grow?
The Revenue of SEPTERNA INC (SEPN) is expected to decline by -42.83% in the next year. Check the estimates tab for more information on the SEPN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SEPTERNA INC (SEPN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SEPN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SEPN, evaluating the profitability, health, valuation and growth aspects
- SEPTERNA INC (SEPN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SEPTERNA INC (SEPN) Sales and EPS estimates to see what analysts future expectations are.
- SEPTERNA INC (SEPN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SEPTERNA INC (SEPN) Insider and Institutional Ownership to learn about the owners and their transactions.
- SEPTERNA INC (SEPN) Stock Chart to make your own analysis
- SEPTERNA INC (SEPN) Latest news and press-releases to stay up to date.
Does SEPTERNA INC (SEPN) stock pay dividends?
SEPN does not pay a dividend.
What is the Price/Earnings (PE) ratio of SEPTERNA INC (SEPN)?
SEPTERNA INC (SEPN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.25).
What is the Short Interest ratio of SEPTERNA INC (SEPN) stock?
The outstanding short interest for SEPTERNA INC (SEPN) is 10.12% of its float. Check the ownership tab for more information on the SEPN short interest.
SEPN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SEPN.
SEPN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SEPN. No worries on liquidiy or solvency for SEPN as it has an excellent financial health rating, but there are worries on the profitability.
SEPN Financial Highlights
Over the last trailing twelve months SEPN reported a non-GAAP Earnings per Share(EPS) of -10.25. The EPS decreased by -53868.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.73% | ||
| ROE | -17.09% | ||
| Debt/Equity | 0 |
SEPN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to SEPN. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 75.79% and a revenue growth -42.83% for SEPN